Skip to main content
. 2023 Feb 15;15(4):1241. doi: 10.3390/cancers15041241

Figure 3.

Figure 3

The functional scale scores of 32 patients treated with curative RCT and HT before and 12 months after treatment for: CF (87.50 ± 16.93 vs. 91.14 ± 16.38, p-value = 0.23), EF (76.73 ± 21.91 vs. 90.36 ± 13.57, p-value = 0.003), PF2 (90.83 ± 11.57 vs. 91.04 ± 12.51, p-value = 0.9), RF2 (83.85 ± 21.37 vs. 88.54 ± 19.13, p-value = 0.36), and SF (83.33 ± 20.73 vs. 94.79 ± 11.54, p = 0.008). The asterisks (*) represent the mean values; ns: non-significant with p-value > 0.05; **: significant with p-value < 0.01.